AMLX Stock Analysis: Buy, Sell, or Hold?
AMLX - Amylyx Pharmaceuticals, Inc. Common Stock
$18.17
0.20 (1.11%)
▲
5d:
-2.83%
30d:
+26.97%
90d:
+14.85%
BUY
MODERATE Confidence
Analysis Updated: Jul 7, 2026 12:00 AM ET
Earnings: Aug 06, 2026
29d
Get Alerted When AMLX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: AMLX shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
💡 BUY OPPORTUNITY: AMLX shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: AMLX is currently trading at $18.17, which is considered extended relative to its 30-day fair value range of $13.73 to $17.51.
Technical Outlook: Technically, AMLX is in a strong uptrend. Immediate support is located at $15.71, while resistance sits at $19.15.
Market Sentiment: AMLX has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $24.40 (+35.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, AMLX is in a strong uptrend. Immediate support is located at $15.71, while resistance sits at $19.15.
Market Sentiment: AMLX has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $24.40 (+35.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$13.73 -
$17.51
Company Quality Score
60/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
63.2%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 35.8% below Wall St target ($24.40)
Trading Range Analysis
30-Day Trading Range
$13.73 -
$17.51
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$15.71
Resistance Level
$19.15
Current Trend
Strong Uptrend
Technical data as of
Jul 7, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-14.19
Wall Street Target
$24.40
(+35.8%)
Revenue Growth (YoY)
-99.6%
Share & Embed Analysis
Last updated: July 07, 2026 4:31 PM ET
Data refreshes hourly during market hours. Next update: 5:31 PM
Data refreshes hourly during market hours. Next update: 5:31 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is AMLX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
3
Sells
Net
INSIDERS SELLING
Recent Transactions
Joshua B Cohen
SELL
1974 shares
2026-01-16
Justin B Klee
SELL
1995 shares
2026-01-16
Joshua B Cohen
SELL
136193 shares
2026-01-15
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$196 | 64 BUY |
|
ZTS
Zoetis Inc |
BUY
20 analysts |
$118 | 59 HOLD |
|
UTHR
United Therapeutics Corp… |
STRONG BUY
15 analysts |
$665 | 57 HOLD |
|
BCRX
BioCryst Pharmaceuticals… |
STRONG BUY
12 analysts |
$22 | 59 HOLD |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$105 | 47 HOLD |
Advanced AMLX Option Strategies
Professional options setups generated by AI based on today's AMLX price and gamma walls.
